RayThera

Series-A Acquired by Biogen
raythera.com Biotech & Healthcare San Diego, United States 1-10
Total Funding $110M
Latest Round $110M Series-A
Last Announced Apr 4, 2025
Investors 3 Backers
Decision Makers 2 Verified

About RayThera

RayThera is dedicated to developing small molecule therapies specifically targeting unmet needs in immunology.

Sectors & Market Categories

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-A
Global Headquarters San Diego, United States
Team Size 1-10
Corporate Status Acquired by Biogen
Tracked Since Oct 1, 2026

Web & Domain Identity

Official Website raythera.com
Domain Registered Date Oct 5, 2019

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Not linked

Company Milestones & Timeline

2 Events
  1. Capital Raise

    Raised $110,000,000 · Series-A

    fundraisingfox.com

  2. Milestone

    Website domain registered

    raythera.com

Investors & Backers

3
Foresite Capital
OrbiMed
Qiji Investment

Funding History

1 Round
Series-A · Apr 4, 2025

Founders & Leadership

2

Gene Hung

Founder

Work email & phone locked Unlock →

Qing Dong

Founder

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts